A brief history of MECP2 duplication syndrome: 20-years of clinical understanding

Table 14 Summary of other medical comorbidities found in patients with MDS reported in the literature; NR = not reported

Feature	Males n/N	Females n/N	Total n/N (%)	References
Anaemia	2/11	NR	2/11 (18%)	[32, 48]
Astigmatism	2/7	NR	2/7 (29%)	[40, 68]
Hearing loss	13/39	NR	13/39 (33%)	[1, 2, 8, 9, 32, 40, 77]
Hypermetropia	23/44	2/7	25/51 (49%)	[12, 25, 26, 74, 77]
Hyperbilirubinaemia	2/9	NR	2/9 (22%)	[16, 40]
Hypothyroidism	2/10	3/7	5/17 (29%)	[25, 32, 43, 53, 71]
Obesity	3/7	1/6	4/13 (31%)	[16, 25, 74]
Thrombocytopaenia	3/19	NR	3/19 (16%)	[17]

ISSN: 1750-1172